Ceritinib in anaplastic thyroid cancer (ATC) with ALK abnormalities. Khan, S. A., Bauman, J. E., Burtness, B., Frankel, A. E., Harper, J., Hughes, R. S., Kurian, P., Myers, L. L., Nedzi, L., Schwartz, D. L., Sumer, B. D., Truelson, J., Zhu, H. AMER SOC CLINICAL ONCOLOGY. 2015

View details for DOI 10.1200/jco.2015.33.15_suppl.tps6085

View details for Web of Science ID 000358036904811